A four-year research project on Ginseng by Professor Jiang Zhihong of the School of Chinese Medicine at Hong Kong Baptist University (HKBU) recently received funding of US$380,000 (about HK$3 million) from the National Institutes of Health (NIH) in the USA, the world's largest research institution and funding body in medical research.
The project titled "Chemoprevention of Lung Cancer with Red Ginseng Extracts" is a collaborative effort initiated by HKBU, Washington University and the University of Houston in the USA. The project was awarded funding from the NIH of more than US$1 million, of which US$380,000 was allocated to Professor Jiang's research. The HKBU team will be responsible for the isolation, fractionation, purification, structural modification and in vivo metabolism studies of ginsenosides of both white and red Ginseng herbs.
Ginseng is one of the most famous herbs in the world and extremely important in Chinese medicine. Professor Jiang has more than 10 years' experience of researching Ginseng and ginsenosides. "I am very pleased that this collaborative project has been funded by the NIH, enabling us to conduct more extensive and comprehensive studies on Ginseng and ginsenosides. I hope that the collaboration will contribute to the elucidation of the active principles of Ginseng for cancer prevention and its underlying mechanisms as well as showcase to the world the advancement of Chinese medicine research in Hong Kong," said Professor Jiang.